Horizon Pharma Inc  

(Public, NASDAQ:HZNP)   Watch this stock  
Find more results for HZNP
8.74
+0.23 (2.70%)
Aug 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.07 - 8.91
52 week 2.11 - 18.30
Open 8.45
Vol / Avg. 2.67M/2.22M
Mkt cap 644.44M
P/E     -
Div/yield     -
EPS -5.05
Shares 73.73M
Beta     -
Inst. own 92%
Aug 7, 2014
Q2 2014 Horizon Pharma Inc Earnings Release - 9:30AM EDT - Add to calendar
Aug 7, 2014
Q2 2014 Horizon Pharma Inc Earnings Call - 8:00AM EDT - Add to calendar
Jun 27, 2014
Horizon Pharma Inc Annual Shareholder Meeting
Jun 24, 2014
Horizon Pharma Inc at JMP Securities Healthcare Conference
Jun 2, 2014
Horizon Pharma Inc at Jefferies Global Healthcare Conference
May 9, 2014
Q1 2014 Horizon Pharma Inc Earnings Release
May 9, 2014
Q1 2014 Horizon Pharma Inc Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -397.20% -201.31%
Operating margin 3.06% -93.57%
EBITD margin - -45.32%
Return on average assets -299.88% -66.73%
Return on average equity - -523.78%
Employees 304 -
CDP Score - -

Address

Suite 520, 520 Lake Cook Road
DEERFIELD, IL 60062
United States - Map
+1-224-3833000 (Phone)
+1-224-3833001 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.

Officers and directors

Timothy P. Walbert Chairman of the Board, President, Chief Executive Officer
Age: 47
Bio & Compensation  - Reuters
Robert J. De Vaere Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Paul W. Hoelscher Chief Financial Officer, Executive Vice President, Principal Financial Officer, Principal Accounting Officer
Age: 49
Bio & Compensation  - Reuters
Robert F. Carey III Executive Vice President, Chief Business Officer
Age: 55
Bio & Compensation  - Reuters
Jeffrey W. Sherman M.D. Chief Medical Officer, Executive Vice President - Development, Regulatory Affairs and Manufacturing
Age: 59
Bio & Compensation  - Reuters
Todd N. Smith Executive Vice President, Chief Commercial Officer
Age: 44
Bio & Compensation  - Reuters
Michael G. Grey Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
Jeffrey W. Bird M.D., Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters
Jeff Himawan Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
Ronald E. Pauli Independent Director
Age: 53
Bio & Compensation  - Reuters